MARKET

WVE

WVE

Wave Life Scienc
NASDAQ
12.80
-0.47
-3.54%
After Hours: 12.83 +0.03 +0.23% 19:37 02/12 EST
OPEN
13.19
PREV CLOSE
13.27
HIGH
13.23
LOW
12.51
VOLUME
3.32M
TURNOVER
--
52 WEEK HIGH
21.73
52 WEEK LOW
5.28
MARKET CAP
2.34B
P/E (TTM)
-17.3842
1D
5D
1M
3M
1Y
5Y
1D
Wave Life Sciences Is Maintained at Overweight by Wells Fargo
Dow Jones · 11h ago
Wave Life Sciences Price Target Cut to $27.00/Share From $29.00 by Wells Fargo
Dow Jones · 11h ago
Wells Fargo Maintains Overweight on WAVE Life Sciences, Lowers Price Target to $27
Benzinga · 11h ago
Wave Life Sciences price target lowered to $27 from $29 at Wells Fargo
TipRanks · 14h ago
Analysts Offer Insights on Healthcare Companies: Medpace Holdings (MEDP), Wave Life Sciences (WVE) and Collegium Pharmaceutical (COLL)
TipRanks · 2d ago
Weekly Report: what happened at WVE last week (0202-0206)?
Weekly Report · 3d ago
Microsoft downgraded, Snap upgraded: Wall Street’s top analyst calls
TipRanks · 02/05 15:16
Wave Life Sciences Is Maintained at Overweight by Cantor Fitzgerald
Dow Jones · 02/05 14:33
More
About WVE
Wave Life Sciences Ltd. is a biotechnology company focused on unlocking the broad potential of ribonucleic acid (RNA) medicines to transform human health. The Company’s RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation and deep insights in human genetics to deliver scientific breakthroughs that treat both rare and common disorders. Its toolkit of RNA-targeting modalities includes editing, splicing, RNA interference and antisense silencing, providing Wave with unmatched capabilities for designing and sustainably delivering candidates that optimally address disease biology. The Company’s diversified pipeline includes clinical programs in alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington’s disease, as well as several preclinical programs utilizing the Company’s broad RNA therapeutics toolkit. Its programs include WVE-006, SERPINA1 (AATD); WVE-007 (GalNAc), INHBE (Obesity); WVE-N531, Exon 53 (DMD), and WVE-003, mHTT (HD).

Webull offers Wave Life Sciences Ltd stock information, including NASDAQ: WVE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, WVE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading WVE stock methods without spending real money on the virtual paper trading platform.